Palmar plantar erythrodysesthesia classification
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mandana Chitsazan, M.D. [2]
Overview
A number of different classifications have been used for grading the severity of palmar plantar erythrodysesthesia (PPE). The classifications suggested by the National Cancer Institute (NCI), and the World Health Organization (WHO) are the two most commonly used.
Classification
- Palmar plantar erythrodysesthesia (PPE) may be classified into 3 grades according to the National Cancer Institute (NCI).[1]
| GRADES | |
|---|---|
| 1 |
|
| 2 |
|
| 3 |
|
- Palmar plantar erythrodysesthesis (PPE) may be classified into 4 grades based on the World Health Organization (WHO). [2]
| GRADES | |
|---|---|
| 1 |
|
| 2 |
|
| 3 | |
| 4 |
|
Gallery
![]() Grades 1–3, according to the National Cancer Institute Common Terminology Criteria for Adverse events, version 4. Images shown above are courtesy of Siegfried Segaert and Eric Van Cutsem |
References
- ↑ “Protocol Development | CTEP”.
- ↑ Nagore E, Insa A, Sanmartín O (2000). “Antineoplastic therapy-induced palmar plantar erythrodysesthesia (‘hand-foot’) syndrome. Incidence, recognition and management”. Am J Clin Dermatol. 1 (4): 225–34. doi:10.2165/00128071-200001040-00004. PMID 11702367.
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH

